A California federal judge recently rejected a proposed settlement that would have resolved a class action lawsuit filed against homeopathic remedy manufacturer Similasan. The class action lawsuit was filed on behalf of two classes of plaintiffs who alleged that the manufacturer’s claims about the effectiveness of its products used to treat earwax, sinus, and anxiety issues were deceptive. The parties notified the federal district court that they had reached a settlement agreement earlier this year, and the court had given preliminary approval to the proposed settlement agreement. However, when the case came back before the court in August 2016 for final approval, the court found sufficient reason to reject the agreement.
Problems with the Class Action Settlement
The federal district judge overseeing the case expressed serious reservations over the terms of the proposed settlement and refused to approve the settlement. Some of the court’s concerns included: